ArticleInternational dental journal2026
Burden, Trends and Projection of Lip and Oral Cavity Cancer in Central, Eastern and Western Europe: From the Global Burden of Disease 2023 Study.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLip and oral cavity cancer (LOCC) remains a significant issue in Europe, with an uneven public health burden. While trends have shifted, regional and sex-specific disparities persist due to modifiable risk factors. Using Global Burden of Disease 1990 to 2023 estimates, this study evaluates long-term trends and projects Europe's future LOCC burden.
methodsThe Global Burden of Disease (GBD) Study data of 2023 were examined to evaluate the trends of incidence, prevalence, and mortality of LOCC in Central, Eastern, and Western Europe. We conducted a retrospective analysis of age-standardized incidence (ASIR), prevalence (ASPR), and mortality rates (ASMR), alongside disability-adjusted life years (ASDR). Trends over time were examined using Joinpoint regression to estimate average Annual Percent Change (AAPC:). Furthermore, ARIMA time-series models were employed to generate future burden for the period 2024 to 2033.
resultsFrom 1990 to 2023, Europe showed a clear East-West divide in LOCC. Western Europe successfully lowered its death rates (AAPC: -1.08%) and disability rates (AAPC: -1.41%). However, Central and Eastern Europe saw new cases rise (AAPC: 0.63% and 0.60%) along with more alcohol-related deaths. The highest burden was in Russia and Hungary, where male DALYs rate reached 207 per 100,000. ARIMA forecasting shows this gap will grow by 2033; while Central Europe's ASIR is expected to fall to 4.65 per 100,000, Eastern Europe's prevalence is projected to rise to 18.12 per 100,000 population.
conclusionEurope highlights widening variations in LOCC burden, with Western Europe achieving substantial progress while Central and Eastern Europe face continuous worsening trends.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.